A5005359407- Lymphoma Diagnosis and Treatment
- Radiomics and Machine Learning in Medical Imaging
- Medical Imaging Techniques and Applications
- Sarcoma Diagnosis and Treatment
- Radiopharmaceutical Chemistry and Applications
- Lung Cancer Treatments and Mutations
- Prostate Cancer Treatment and Research
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Meningioma and schwannoma management
- Neuroblastoma Research and Treatments
- Advanced X-ray and CT Imaging
- Cancer Genomics and Diagnostics
- Myasthenia Gravis and Thymoma
- Advanced Radiotherapy Techniques
- Genetic factors in colorectal cancer
- Pituitary Gland Disorders and Treatments
- Medical Imaging and Pathology Studies
- Viral-associated cancers and disorders
- Protease and Inhibitor Mechanisms
- Cardiac tumors and thrombi
- Hepatocellular Carcinoma Treatment and Prognosis
- Cardiac Structural Anomalies and Repair
Istituti di Ricovero e Cura a Carattere Scientifico
2018-2025
Agostino Gemelli University Polyclinic
2021-2025
Advanced Radiation Therapy (United States)
2024
Politecnico di Milano
2023
Università Cattolica del Sacro Cuore
2013-2022
University of the Sacred Heart
2022
National Cancer Institute
2020
Istituti Fisioterapici Ospitalieri
2019
Catholic University of America
2013-2014
Aggressive histological subtypes of thyroid cancer are rare and have a poor prognosis. The most important aggressive Hürthle cell carcinoma (HCTC) anaplastic poorly differentiated (ATC PDTC). American Thyroid Association recently published guidelines for the management patients with ATC, but no specific been done about HCTC. We performed an overview literature role Fluorine-18-Fluorodeoxyglucose positron emission tomography or tomography/computed (FDG-PET PET/CT) in cancer. Only few original...
This study investigated whether radiomic features extracted from pretreatment [<sup>18</sup>F]FDG PET could improve the prediction of both histopathologic tumor response and survival in patients with locally advanced cervical cancer (LACC) treated neoadjuvant chemoradiotherapy followed by surgery compared conventional parameters features. <b>Methods:</b> The medical records all consecutive LACC referred between July 2010 2016 were reviewed. PET/CT was performed before chemoradiotherapy....
Coronavirus disease-19 (COVID-19) pandemic is challenging the availability of hospital resources worldwide. The Young Group Italian Association Nuclear Medicine (AIMN) developed first international survey to evaluate impact COVID-19 in nuclear medicine (NM). aim this study was perform a preliminary report ongoing survey.
In a previous preliminary study, radiomic features from the largest and hottest lesion in baseline 18F-FDG PET/CT (bPET/CT) of classical Hodgkin's Lymphoma (cHL) predicted early response-to-treatment prognosis. Aim this large retrospectively-validated study is to evaluate predictive role two-lesions radiomics comparison with other clinical conventional models. cHL patients bPET/CT between 2010 2020 were retrospectively included randomized into training-validation sets. Target lesions were:...
Background: Patients with low tumour burden follicular lymphoma (FL) are managed an initial watchful waiting (WW) approach. The way to better predict the time-to-treatment (TTT) is still under investigation for its possible clinical impact. This study explored whether radiomic features extracted from baseline 18F-FDG PET/CT could TTT in FL patients on WW. Methods: Thirty-eight WW (grade 1–3a) were retrospectively included 2010 2019. Eighty-one morphological and first-level intensity total...
Abstract Early response evaluation with [ 18 F]fluordeoxyglucose ( FDG ) positron emission tomography after 2 cycles of chemotherapy (interim PET has been indicated as the strongest predictor for outcome in classical Hodgkin lymphoma HL ). We studied prognostic role number tumor‐infiltrating CD 68+ cells and plasma levels TARC (thymus activation‐regulated chemokine) context interim 102 patients treated Adriamycin, Bleomycin, Vinblastine, Dacarbazine ABVD After cycles, according to Deauville...
A significant number of meta-analyses reporting data on the diagnostic performance positron emission tomography (PET) in prostate cancer (PCa) is currently available literature. In particular, different PET radiopharmaceuticals were used for this purpose. The aim review to summarize information retrieved by published topic. first step included a systematic search literature (last date: June 2020), screening two databases (PubMed/MEDLINE and Cochrane Library). This combination key words was...